BCL2 and neoplasm: In most cases, suppression of cell death delays involution and facilitates tumor progression, e.g. in mice expressing Akt1 (Hutchinson et al., 2001), ERBB2 (Castillo-Lluva et al., 2015) or Bcl2 (Jäger et al., 1997).